Incyte (INCY) Payables (2010 - 2026)
Incyte (INCY) posted Payables of $250.4 million for Q2 2026, up 3.9% from $241.09 million a year earlier and up 9.5% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Incyte's Payables came in at $209.94 million, up 6.3% from FY2024.
- Annual Payables shows a five-year compound annual growth rate of 16.3% (FY2020 to FY2025).
- In prior years, Incyte's Payables was $197.47 million in FY2024 (+80.2%), $109.6 million in FY2023 (-60.5%), $277.55 million in FY2022 (+61.3%) and $172.11 million in FY2021 (+74.3%).
- The Q2 2026 figure stands as the highest quarterly Payables since Q4 2022.
- On a year-over-year basis, Payables has increased in each of the last three quarters, with growth averaging 26.7% over the last eight quarters.
- The strongest year-over-year quarter for Payables in the past five years was Q1 2024, with growth of 195.2%; the weakest was Q1 2023, with a decline of 63.5%.
- According to Business Quant data, Payables for the three prior quarters was $228.62 million (Q1 2026), $209.94 million (Q4 2025) and $171.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn | 250.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 250.40 Mn |
| Mar 31, 2026 | 228.62 Mn |
| Dec 31, 2025 | 209.94 Mn |
| Sep 30, 2025 | 171.93 Mn |
| Jun 30, 2025 | 241.09 Mn |
| Mar 31, 2025 | 195.54 Mn |
| Dec 31, 2024 | 197.47 Mn |
| Sep 30, 2024 | 178.71 Mn |
| Jun 30, 2024 | 148.17 Mn |
| Mar 31, 2024 | 164.24 Mn |
| Dec 31, 2023 | 109.60 Mn |
| Sep 30, 2023 | 139.41 Mn |
| Jun 30, 2023 | 155.54 Mn |
| Mar 31, 2023 | 55.63 Mn |
| Dec 31, 2022 | 277.55 Mn |
| Sep 30, 2022 | 163.18 Mn |
| Jun 30, 2022 | 194.77 Mn |
| Mar 31, 2022 | 152.55 Mn |
| Dec 31, 2021 | 172.11 Mn |
| Sep 30, 2021 | 114.51 Mn |
API Access
Incyte Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();